Company intelligence
Bridge to Life Ltd.
Proven solutions. Purposeful innovation. Uncompromising quality.
About Bridge to Life Ltd.
Bridge to Life was founded with the mission of improving organ transplants through licensing and developing new preservation solutions and technologies to provide the highest quality of service to organ procurement organizations and transplant centers. Bridge to Life is a leading supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion. Through a strong focus on collaboration with surgeons and transplant professionals, we continue to explore emerging science and preservation technologies.
Verified activity
Signals from Bridge to Life Ltd.
5 published signals
Presence & Recognition
Bridge to Life Ltd. is attending the TTS 2026 event in Sydney for the Breakfast Symposium Scaling Better Outcomes: The Role of HOPE in Contemporary Transplant Programs on September 22.
Reported by Bridge to Life Ltd.
Presence & Recognition
Bridge to Life Ltd. US team had a team meeting last weekend on the lake setting.
Reported by Bridge to Life Ltd.
Presence & Recognition
Bridge to Life Ltd. demonstrated the VitaSmart Hypothermic Oxygenated Perfusion System and the VitaSmart HOPE system at the NCIF 2026 National Critical Issues Forum in New Orleans.
Reported by Bridge to Life Ltd.
Operations & Supply
Bridge to Life Ltd. installed the latest VitaSmart™ HOPE System in Asturias, Spain for hands-on training and education for the local clinical team.
Reported by Bridge to Life Ltd.
Legal & Regulatory
Bridge to Life Ltd. received NHS funding for ex-situ machine perfusion technologies following a rigorous evaluation by the NICE National Institute for Health and Care Excellence.
Reported by Bridge to Life Ltd.